Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01885468 · ClinicalTrials.gov registry record
X-Ray Verified Accuracy of the proGAV Verification Instrument
A clinical trial, sponsored by Aesculap.
- Completed
- Registry status
- 12
- Enrollment target
NCT01885468: Completed study, sponsored by Aesculap.
NCT01885468 is a clinical trial that has completed, run by Aesculap. The registered enrollment target is 12 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01885468 has completed, sponsored by Aesculap.
- COMPLETED
- Registry status
- 12 participants
- Enrollment target
Study Summary
This study is to verify the use of a hand held tool to verify the new setting of a hydrocephalus shunt (proGAV). This tool would be used in place of an Xray of the patient's head, which is how settings are verified currently.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2013-05 |
| Est. Completion | 2016-06 |
What the finished NCT01885468 record still lists
NCT01885468 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 12 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT01885468 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01885468 about?
NCT01885468 is a clinical study titled "X-Ray Verified Accuracy of the proGAV Verification Instrument". This study is to verify the use of a hand held tool to verify the new setting of a hydrocephalus shunt (proGAV). This tool would be used in place of an Xray of the patient's head, which is how settings are verified currently.
What is the current status of trial NCT01885468?
This trial is currently completed. The enrollment target is 12 participants. The study started on 2013-05. Estimated completion is 2016-06.
Who is sponsoring clinical trial NCT01885468?
This trial is sponsored by Aesculap, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02602769 · 12 participants
Whole Transcriptome Profiling and Metabolic Phenotyping in Children With ROHHAD Syndrome
- NCT02605421 · 12 participants · Phase 2
Myeloablative Consolidation Therapy and Tandem Autologous Stem Cell Rescue in Patients With High-Risk Neuroblastoma
- NCT02619448 · 12 participants · Early Phase 1
Concurrent Chemotherapy Plus HFR Radiation Therapy in Inoperable NSCLC
- NCT03311503 · 12 participants · Phase 1
Phase I/II Trial of Lentiviral Gene Transfer for SCID-X1 With Low Dose Targeted Busulfan Conditioning
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia